CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 7 No. 3
 

Panel Says Test Certain Herbs, Additives for Carcinogenesis

March 1, 1998

RESEARCH TRIANGLE PARK, NC--A federal panel has recommended to the National Toxicology Program (NTP) that it review and possibly test a group of products, including three herbs, for their potential to cause cancer or to lead to reproductive and developmental problems.

The recommendations of the Inter-agency Committee for Chemical Evaluation and Coordination were released by Kenneth Olden, PhD, director of the National Institute of Environmental Health Sciences (NIEHS) and the NTP, which is headquartered at the NIEHS.

"A recommendation for testing does not necessarily mean a substance is a carcinogen or mutagen but often reflects--as in several of these cases--that substances have gone into widespread use without as much testing as, in retrospect, we would like," he said.

The products recommended for review include 2-acetylpyridine, which is a fragrance material, direct food additive, and constituent of natural essential oils; and myristicin, which occurs naturally in carrots and parsley, and in certain spices such as black pepper, anise, nutmeg, and mace.

Also on the list are 2-chloropyridine, an intermediate chemical in the manufacture of some cosmetics, pharmaceutical, and agricultural products, with considerable occupational exposure; and glycoluril, a slow-release nitrogen fertilizer, whose resins have also been used in paint and other coatings.

Two Fiber Brighteners

The panel also listed two fiber brighteners: 4-mythoxy-N-methyl-1,8-naph-thalimide, a fluorescent agent used for synthetic fibers and as a coating for specialized papers; and 7-(2H-napthol[1,2-d]triazol-2-yl)-3-phenylcourmarin, used not only as a fabric brightener but also in plastics, photographic film, toners, and food packaging.

Finally the advisory committee urged that the NTP review three herbs--comfrey, goldenseal, and saw palmetto.

Comfrey, available commercially as a powdered root or leaf, as well as in capsule form, is espoused by some for use as an anticancer agent, sedative, stimulant, diuretic, and antihemorrhagic. It is also sold for use in salads and as a herbal tea. In 1993, following reports of toxic effects after the ingestion of comfrey, the American Herbal Products Association recommended that the herb only be used externally.

Goldenseal, which grows in the hardwood forests of Canada and the eastern United States, is sometimes used as a self-prescribed medicine for a wide range of health problems, including cancer, digestive and hemorrhagic disorders, upper respiratory congestion, mucous membrane inflammation, and skin and eye problems. Its constituent alkaloids berberine(Drug information on berberine) and hydrastine would also be studied for potential car-cinogenesis.

Saw palmetto ranks sixth on the list of best-selling dietary supplements in the United States and is used extensively to self-treat benign prostate hyperplasia (BPH). Controlled studies have failed to find it effective for the disorder, and the FDA considers it mislabeled when sold for the treatment of BPH.

Make-up of the Committee

The interagency committee consists of representatives from the National Cancer Institute, Consumer Product Safety Commission, National Institute of Occupational Safety and Health, Agency for Toxic Substances and Disease Registry, Food and Drug Administration, National Library of Medicine, Occupational Safety and Health Administration, Department of Defense, Environmental Protection Agency, and National Institute of Environmental Health Sciences.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy